0000000000878530

AUTHOR

Takaaki Tanaka

0000-0002-4383-0368

Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib

Background and Aim: Lenvatinib is a standard of care option in first-line therapy of advanced hepatocellular carcinoma (HCC). In the present study, we aim to identify, in patients with HCC treated with lenvatinib, a possible association between occurrence and grading of adverse events (AEs) and outcome. Methods: We performed a retrospective analysis of 606 Japanese and Italian patients treated with lenvatinib in first-line setting and investigated the possible correlation between the onset of AEs, toxicity grade (G) and outcome measures such as overall survival (OS) and progression-free survival (PFS). Results: The appearance of arterial hypertension G ≥ 2 independently predicted prolonged …

research product

Deep XMM-Newton Observations Reveal the Origin of Recombining Plasma in the Supernova Remnant W44

Recent X-ray studies revealed over-ionized recombining plasmas (RPs) in a dozen mixed-morphology (MM) supernova remnants (SNRs). However, the physical process of the over-ionization has not been fully understood yet. Here we report on spatially resolved spectroscopy of X-ray emission from W44, one of the over-ionized MM-SNRs, using XMM-Newton data from deep observations, aiming to clarify the physical origin of the over-ionization. We find that combination of low electron temperature and low recombination timescale is achieved in the region interacting with dense molecular clouds. Moreover, a clear anti-correlation between the electron temperature and the recombining timescale is obtained f…

research product